ArticleClinical practice and cases in emergency medicine2026
Berberine Poisoning with Polymorphic Ventricular Tachycardia: A Case Report.
Article in Clinical practice and cases in emergency medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionNatural supplements are readily available without a prescription and are not regulated by the United States Food and Drug Administration. The popularity of berberine, a bioactive compound used for centuries in traditional Chinese medicine, has surged due to its proposed benefits in glycemic control and cardiovascular health. However, use of berberine may lead to possible negative electrophysiologic changes. CASE REPORT: A 92-year-old male presented to the emergency department (ED) with chief complaints of tremors, urinary incontinence, and brief syncopal episodes that began approximately two weeks after starting berberine. In the ED he had multiple episodes of polymorphic ventricular tachycardia with pulselessness requiring immediate cardioversion, with a rapid return of spontaneous circulation between episodes. Amiodarone was started; however, despite this, he continued to have persistent episodes. Finally, the episodes resolved after starting lidocaine and isoproterenol in the intensive care unit. The patient's workup was notable for heart rate-corrected QT interval (QTc) prolongation (QTc 616 milliseconds (ms) [male reference range, QTc < 430 ms]) confirming the polymorphic ventricular tachycardia as torsades de pointes. His cardiac evaluation was otherwise normal, including a normal ejection fraction on a transthoracic echocardiogram. Withholding berberine and supportive management resulted in an improved QTc. On hospital day 3, the QTc was 454 ms. The patient had a short inpatient admission and was discharged without any further episodes.
conclusionBerberine has numerous effects and is purported to have beneficial effects and cardioprotective properties. Due to induced bradycardia and QT prolongation, patients who take berberine can be vulnerable to life-threatening arrhythmias, such as the R-on-T phenomenon in our patient's case. Additional research on berberine is needed to better inform clinician-patient discussions about its use.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.